L. Tomlinson

First name
L.
Middle name
A.
Last name
Tomlinson
Wilkinson, S., Douglas, I. J., Williamson, E., Stirnadel-Farrant, H. A., Fogarty, D., Pokrajac, A., et al. (2018). Factors associated with choice of intensification treatment for type 2 diabetes after metformin monotherapy: a cohort study in UK primary care. Clin Epidemiol. http://doi.org/10.2147/clep.s176142
Iwagami, M., Tomlinson, L. A., Mansfield, K. E., Douglas, I. J., Smeeth, L., & Nitsch, D. (2018). Gastrointestinal bleeding risk of selective serotonin reuptake inhibitors by level of kidney function: A population-based cohort study. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.13660
Iwagami, M., Caplin, B., Smeeth, L., Tomlinson, L. A., & Nitsch, D. (2018). Chronic kidney disease and cause-specific hospitalisation: a matched cohort study using primary and secondary care patient data. Br J Gen Pract. http://doi.org/10.3399/bjgp18X697973
Mansfield, K. E., Douglas, I. J., Nitsch, D., Thomas, S. L., Smeeth, L., & Tomlinson, L. A. (2018). Acute kidney injury and infections in patients taking antihypertensive drugs: a self-controlled case series analysis. Clin Epidemiol. http://doi.org/10.2147/clep.s146757
Sinnott, S. J., Smeeth, L., Williamson, E., Perel, P., Nitsch, D., Tomlinson, L. A., & Douglas, I. J. (2019). The comparative effectiveness of fourth-line drugs in resistant hypertension: An application in electronic health record data. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.4808
Bidulka, P., Fu, E. L., Leyrat, C., Kalogirou, F., McAllister, K. S. L., Kingdon, E. J., et al. (2020). Stopping renin-angiotensin system blockers after acute kidney injury and risk of adverse outcomes: parallel population-based cohort studies in English and Swedish routine care. BMC Med. http://doi.org/10.1186/s12916-020-01659-x
Greenhall, G. H. B., Mansfield, K. E., Nitsch, D., Iwagami, M., Leyrat, C., Johnston, R., et al. (2020). The effect of initiation of renin-angiotensin system inhibitors on haemoglobin: A national cohort study. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.14429
Wilkinson, S., Williamson, E., Pokrajac, A., Fogarty, D., Stirnadel-Farrant, H., Smeeth, L., et al. (2020). Comparative effects of sulfonylureas, DPP4is and SGLT2 inhibitors added to metformin monotherapy: a propensity-score matched cohort study in UK primary care. Diabetes Obes Metab. http://doi.org/10.1111/dom.13970
Bidulka, P., Iwagami, M., Mansfield, K. E., Kalogirou, F., Wong, A. Y. S., Douglas, I. J., et al. (2020). Comparisons of Staphylococcus aureus infection and other outcomes between users of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers: lessons for COVID-19 from a nationwide cohort study. Wellcome Open Res. http://doi.org/10.12688/wellcomeopenres.15873.1
Hayes, J. F., Osborn, D. P. J., Francis, E., Ambler, G., Tomlinson, L. A., Boman, M., et al. (2021). Prediction of individuals at high risk of chronic kidney disease during treatment with lithium for bipolar disorder. BMC Med. http://doi.org/10.1186/s12916-021-01964-z